Multihance
Multihance Brand names, Multihance Analogs
Multihance Brand Names Mixture
- No information avaliable
Multihance Chemical_Formula
C22H28GdN3O11
Multihance RX_link
No information avaliable
Multihance fda sheet
Multihance msds (material safety sheet)
Multihance Synthesis Reference
No information avaliable
Multihance Molecular Weight
667.7 g/mol
Multihance Melting Point
No information avaliable
Multihance H2O Solubility
No information avaliable
Multihance State
No information avaliable
Multihance LogP
No information avaliable
Multihance Dosage Forms
Liquid; Solution
Multihance Indication
For magnetic resonance imaging (MRI) of the central nervous system in adults to visualize lesions with abnormal blood brain barrier or abnormal vascularity of the brain, spine, and associated tissues.
Multihance Pharmacology
Gadobenate dimeglumine shares the pharmacokinetic properties of the ECF contrast agent gadopentetate dimeglumine; however, gadobenate differs in that is also selectively taken-up by hepatocytes and excreted via the bile (up to 5% of dose). The elimination half-life of gadobenate dimeglumine is approximately 1 hour. It is not metabolized.
Multihance Absorption
No information avaliable
Multihance side effects and Toxicity
No information avaliable
Multihance Patient Information
No information avaliable
Multihance Organisms Affected
Humans and other mammals
